POLICY IMPACT COMMUNICATIONS, INC.

Lobbying for CHROMADEX · Niagen bioscience focusing on the potential of NAD+.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · posted May 1, 2026

Lobbying activity 1

Health Issues

Protecting DSHEA.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem